Pages that link to "Q44254188"

The following pages link to Inhibitory potency of various peptides on enkephalinase activity from mouse striatum (Q44254188):

Displaying 23 items.

• Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs. (Q34602588) (← links)
• Neurohormones regulate T cell function (Q36351097) (← links)
• A cyclic enkephalin analog with high in vitro opiate activity (Q36418394) (← links)
• Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan (Q37613022) (← links)
• Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl-carboxypeptidase (“enkephalinase”) as neuropeptidase (Q40126762) (← links)
• Pituitary endopeptidases (Q40151657) (← links)
• Degradation of enkephalins: the search for an enkephalinase (Q40245354) (← links)
• Inhibitors of enkephalin-degrading enzymes as potential therapeutic agents. (Q40811955) (← links)
• Evidence that Asn542 of neprilysin (EC 3.4.24.11) is involved in binding of the P2' residue of substrates and inhibitors (Q41282590) (← links)
• Differential recognition of “enkephalinase” and angiotensin-converting enzyme by new carboxyalkyl inhibitors (Q42246118) (← links)
• Novel inhibitors of enkephalin-degrading enzymes. I: Inhibitors of enkephalinase by penicillins (Q43558284) (← links)
• Novel inhibitors of enkephalin-degrading enzymes. III: 4-Carboxymethylamino-4-oxo-3 (phenylamino) butanoic acids as enkephalinase inhibitors (Q45215503) (← links)
• Synthesis and in vitro Evaluation of Trifluoroethylamine Analogues of Enkephalins. (Q45965980) (← links)
• Transdermal delivery of bioactive peptides: the effect of n-decylmethyl sulfoxide, pH, and inhibitors on enkephalin metabolism and transport. (Q54011603) (← links)
• The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice (Q59063903) (← links)
• Presence of a histidine at the active site of the neutral endopeptidase-24.11 (Q68907290) (← links)
• Differences in the structural requirements for selective interaction with neutral metalloendopeptidase (enkephalinase) or angiotensin-converting enzyme. Molecular investigation by use of new thiol inhibitors (Q70190686) (← links)
• Investigation into the intestinal metabolism of [d-Ala1] Peptide T amide: implication for oral drug delivery (Q72009049) (← links)
• Inhibition of enkephalin-degrading aminopeptidase activity by certain peptides (Q72443195) (← links)
• D-Tyr-Ser-Gly-Phe-Leu-Thr, a highly preferential ligand for δ-opiate receptors (Q72865138) (← links)
• Specific binding for opiate-like drugs in the placenta (Q72867388) (← links)
• Binding and metabolism studies with [3H](D-Ala2, Leu5)enkephalinamide and [3H](D-Ala2, Pro5)enkephalinamide: Evidence for a selective interaction of (D-Ala2,Pro5)enkephalinamide with μ-receptors (Q72911824) (← links)
• Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression (Q74033290) (← links)